Varying temperature-dependence of post-attachment neutralization of human immunodeficiency virus type 1 by monoclonal antibodies to gp120: identification of a very early fusion-independent event as a neutralization target

References

1. Arendrup M., Sönnerborg A., Svennerholm B., Ãkerblom L., Nielsen C., Clausen H., Olofsson S., Nielsen J. O., Hansen J.-E. S. 1993; Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape. Journal of General Virology 74:855–863
   [Google Scholar]
2. Blumenthal R., Bali-Puri A., Walter A., Covell D., Eidelman O. 1987; pH-dependent fusion of vesicular stomatitis virus with Vero cells. Journal of Biological Chemistry 262:I36I4–13619
   [Google Scholar]
3. Boeyé A., Delaet I., Brioen P. 1994; Antibody neutralization of picomaviruses: can fever help?. Trends in Microbiology 2:255–257
   [Google Scholar]
4. Colonno R. J., Callahan P. L., Leippe D. M., Rueckert R. R., Tomassini J. E. 1989; Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments. Journal of Virology 63:36–42
   [Google Scholar]
5. Cordell J., Moore J. P., Dean C. J., Klasse P. J., Weiss R. A., Mckeating J. A. 1991; Rat monoclonal antibodies to non-overlapping epitopes of HIV-I gp120 block CD4-binding in vitro. Virology 185:72–79
   [Google Scholar]
6. Dietzschold B., Tollis M., Lafon M., Wunner W. H., Koprowski H. 1987; Mechanisms of rabies virus neutralization by glycoprotein specific monoclonal antibodies. Virology 161:29–36
   [Google Scholar]
7. Dimitrov D. S., Hillman K., Manischewitz J., Blumenthal R., Golding H. 1992; Kinetics of soluble CD4-binding to cell expressing human immunodeficiency virus type 1 envelope glycoprotein. Journal of Virology 66:132–138
   [Google Scholar]
8. Dimmock N. J. 1993; Neutralization of animal viruses. Current Topics in Microbiology and Immunology 183:1–149
   [Google Scholar]
9. Dimmock N. J. 1995; Update on the neutralisation of animal viruses. Reviews in Medical Virology 5:165–179
   [Google Scholar]
10. Frey S., Marsh M., Gánther S., Pelchen-Matthews A., Stephens P., Ortlepp S., Stegmann T. 1995; Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1. Journal of Virology 69:1462–1472
    [Google Scholar]
11. Gollins S., Porterfield J. S. 1986; A new mechanism for the neutralization of enveloped viruses by antiviral antibody. Nature 321:244–246
    [Google Scholar]
12. Healy D., Dianda L., Moore J. P., McDougal J. S., Moore M. J., Estess P., Buck D., Kwong P. D., Beverley P. C. L., Sattentau Q. J. 1990; Novel anti-CD4 monoclonal antibodies separate HIV infection and fusion of CD4 + cells from virus binding. Journal of Experimental Medicine 172:1233–1242
    [Google Scholar]
13. Ho D. D., Kaplan J. C., Rackauskas I. E., Gurney M. E. 1988; Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization. Science 239:1021–1023
    [Google Scholar]
14. Iorio R. M., Glickman R. L., Riel A. M., Sheehan J. P., Bratt M. A. 1989; Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent attachment. Virus Research 13:245–262
    [Google Scholar]
15. Ishada N., Ackerman W. W. 1956; Growth characteristics of influenza virus. Properties of the initial cell–virus complex. Journal of Experimental Medicine 104:501–505
    [Google Scholar]
16. Kjellén L. 1985; A hypothesis accounting for the effect of the host cell on neutralization-resistant virus. Journal of General Virology 66:2279–2283
    [Google Scholar]
17. McDougal J. S., Nicholson J. K. A., Cross G. D., Cort S. P., Kennedy M. S., Mawle A. C. 1986; Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. Journal of Immunology 137:2937–2944
    [Google Scholar]
18. McKeating J. A. 1992; Neutralization of human immunodeficiency virus. Reviews in Medical Virology 2:35–42
    [Google Scholar]
19. McKeating J. A., Cordell J. A., Dean C. J., Balfe P. 1992a; Synergistic interaction between ligands binding to the CD4-binding site and V3 domain of human immunodeficiency virus type 1 gp120. Virology 191:732–742
    [Google Scholar]
20. McKeating J. A., Thali M., Furman C., Karwowska S., Gorny M. K., Cordell J., Zolla-Pazner S., Sodroski J., Weiss R. A. 1992b; Amino acid residues of the human immunodeficiency virus type I gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction. Virology 190:134–142
    [Google Scholar]
21. McLain L., Dimmock N. J. 1994; Single- and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodies. Journal of General Virology 75:1457–1460
    [Google Scholar]
22. Montefiori D. C., Graham B. S., Zhou J., Bucco R. A., Schwartz D. M., Cavacini L. A., Posner M. R. NIH-NAIAD Aids Vaccine Clinical Trials Network 1993; V3-specific neutralizing antibodies in sera from HIV-1 gpl60-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformationdependent CD4-binding site of gp120. Journal of Clinical Investigation 92:840–847
    [Google Scholar]
23. Moore J. P., Ho D. D. 1993; Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. Journal of Virology 67:863–875
    [Google Scholar]
24. Moore J. P., Klasse P. J. 1992; Thermodynamic and kinetic analysis of sCD4-binding to HIV-1 virions and gp120 dissociation. AIDS Research and Human Retroviruses 8:443–450
    [Google Scholar]
25. Nara P. L. 1988; Neutralization of HIV1: a binding/post-binding event mediated through the gp120 immunodominant epitope. In Troisieme Colloque des Cent Gardes pp 138–150 Edited by Girard M., Valette L. Paris: Pasteur Vaccins;
    [Google Scholar]
26. Nara P. L. 1989; HIV-neutralization: evidence for rapid, binding/ post-binding neutralization from infected humans, chimpanzees and gp 120-vaccinated animals. In Vaccines 89: Modem Approaches to New Vaccines including the Prevention of AIDS pp 137–144 Edited by Lerner R. A. Ginsberg H., Chanock R. M., Brown F. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
27. Ohizumi Y., Suzuki H., Matsumoto Y.-I., Mashuo Y., Numazaki Y. 1992; Neutralizing mechanisms of two human monoclonal antibodies against human cytomegalovirus glycoprotein 130/55. Journal of General Virology 73:2705–2707
    [Google Scholar]
28. Osiowy C., Anderson R. 1995; Neutralization of repiratory syncytial virus after cell attachment. Journal of Virology 69:1271–1274
    [Google Scholar]
29. Outlaw M. C., Dimmock N. J. 1993; IgG-neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway. Virology 195:413–421
    [Google Scholar]
30. Posner M. R., Hideshima T., Cannon T., Mukherjee M., Mayer K. H., Byrn R. A. 1991; An IgG human monoclonal antibody that reacts with HIV-l/gp120, inhibits virus binding to cells, and neutralizes infection. Journal of Immunology 146:4325–4332
    [Google Scholar]
31. Rieber E. P., Federle C., Reiter C., Krauss S., Gürtler L., Eberle J., Deinhardt F., Riethmuller G. 1992; The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to post-exposure prophylaxis. Proceedings of the National Academy of Sciences, USA 89:10792–10796
    [Google Scholar]
32. Roehrig J. T., Hunt A. R., Kinney R. M., Mathews J. H. 1988; In vitro mechanisms of monoclonal antibody neutralization of alphaviruses. Virology 165:66–73
    [Google Scholar]
33. Russell P. H. 1984; Newcastle disease virus: the effect of monoclonal antibody in the overlay on virus penetration and the immunoselection of variants. Journal of General Virology 65:795–798
    [Google Scholar]
34. Skinner M. A., Langlois A. J., McDanal C. B., McDougal J. S., Bolognesi D. P., Matthews T. J. 1988; Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. Journal of Virology 62:4195–4200
    [Google Scholar]
35. Smith T. J., Olson N. H., Cheng R. H., Liu H., Chase E. S., Lee W. M., Leippe D. M., Mosser A. G., Rueckert R. R., Baker T. S. 1993; Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody. Journal of Virology 67:1148–1158
    [Google Scholar]
36. Sun N.-C., Ho D. D., Sun C. R. Y., Liou R.-S., Gordon W., Fung M. S. C., Li X.-L., Ting R. C., Lee T.-H., Chang N. T., Chang T.-W. 1989; Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120. Journal of Virology 63:3579–3585
    [Google Scholar]
37. Suñé C., Jimenez G., Correa I., Bullido M. J., Gebauer F., Smerdou C., Enjuanes L. 1990; Mechanisms of transmissible gastroenteritis coronavirus neutralization. Virology 177:559–569
    [Google Scholar]
38. Thali M., Furman C., Ho D. D., Robinson J. E., Tilley S. A., Pinter A., Sodroski J. 1992; Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein. Journal of Virology 66:5635–5641
    [Google Scholar]
39. Thali M., Moore J. P., Furman C., Charles M., Ho D. D., Robinson J., Sodroski J. 1993; Characterization of conserved human immundeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4-binding. Journal of Virology 67:3978–3988
    [Google Scholar]
40. Vrijsen R., Mosser A., Boeyé A. 1993; Postadsorbtion neutralization of poliovirus. Journal of Virology 67:3126–3133
    [Google Scholar]
41. Wohlfart C. 1988; Neutralization of adenoviruses: kinetics, stoichiometry and mechanisms. Journal of Virology 62:2321–2328
    [Google Scholar]